Evidence map›Paper›PMID 38553792›Full record

ArticleJournal of diabetes investigation2024

Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice.

Shengping Lei, Xin Lu, Lei Yan, Tian Liu, Yan Niu, Jun Yu

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Shengping LeiClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Xin LuClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Lei YanClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Tian LiuClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Yan NiuClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Jun YuClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.ORCID https://orcid.org/0009-0000-3795-6346
Medical Center Hospital · US

Funding

National Natural Science Foundation of China - State Grid Corporation Joint Fund for Smart Grid 81870172Shaanxi Administration of Traditional Chinese Medicine 2019-ZZ-JC050Shaanxi Science and Technology Association 2022JQ-824Xi'an International Medical Center Hospital 2020QN006Xi'an municipal health commission 2023qn21
6 · The paper itself

Abstract

AIMS/

introductionDiabetic cardiomyopathy (DCM) is a prevalent condition among individuals with diabetes, and is associated with a high mortality rate. The anti-oxidant properties of Jing Huang or Polygonatum sibiricum polysaccharide (PSP) have been extensively used to treat diabetes-related disorders; however, its potential effectiveness against DCM remains unknown. This study aimed to investigate PSP's therapeutic effects on DCM in an experimental diabetic mouse model. MATERIALS AND

methodsTo induce insulin resistance, mice were fed a high-fat diet for 3 months, followed by intraperitoneal streptozotocin injection to induce slight hyperglycemia and develop DCM. Both DCM and control mice were given PSP orally for 3 weeks. Western blotting was used to detect the protein expressions of protein kinase G, C/EBP homologous protein, glucose-regulated protein 78, phosphodiesterase type 5, protein kinase R-like endoplasmic reticulum (ER) kinase, and phospho-protein kinase R-like endoplasmic reticulum kinase in heart tissue.

resultsThe results showed a reduction in bodyweight and blood glucose levels in the PSP therapy group compared with DCM group. PSP also improved cardiac function and had a negligible effect on malondialdehyde activity. Furthermore, the findings showed that PSP alleviated ER and oxidative stress observed in DCM mice hearts, leading to the inhibition of cyclic guanosine monophosphate-specific phosphodiesterase type 5 and cardiac cyclic guanosine monophosphate reactivation. Phosphodiesterase type 5 inhibition reduced high-fat diet-induced cardiac dysfunction and decreased ER stress.

conclusionsPSP could effectively protect diabetic myocardium by inhibiting endoplasmic reticulum stress. These findings provide crucial insights into the potential of PSP to ameliorate DCM conditions in diabetic mice by decreasing ER and oxidative stress, and enhancing cyclic guanosine monophosphate protein kinase G signaling.

Indexed as

Diabetes Mellitus, ExperimentalDiabetic CardiomyopathiesDrugs, Chinese HerbalPolygonatumPolysaccharidesSignal TransductionAnimalsAstragalus propinquusCyclic GMPCyclic GMP-Dependent Protein KinasesDiet, High-FatEndoplasmic Reticulum StressMaleMiceMice, Inbred C57BLOxidative StressCyclic GMPCyclic GMP-Dependent Protein KinasesDrugs, Chinese HerbalHuang QiPolysaccharidesDiabetic cardiomyopathyPolygonatum sibiricum polysaccharideReactive oxygen species

Identifiers

PMID38553792
PMCPMC11215682
OpenAlexW4393344743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.